Global Scopolamine Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Scopolamine Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Scopolamine is a medication used in the treatment of motion sickness and postoperative nausea and vomiting. Scopolamine is used to prevent nausea and vomiting caused by motion sickness or from anesthesia given during surgery.
Scopolamine report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Scopolamine market is projected to reach US$ 15 million in 2034, increasing from US$ 11 million in 2022, with the CAGR of 4.2% during the period of 2024 to 2034. Demand from Tablets and Injection are the major drivers for the industry.
The major players in global Scopolamine market include Alkaloids of Australia, Boehringer Ingelheim, Fine Chemicals Corporation, etc. The top 3 players occupy about 55% shares of the global market. Australia and Europe are main markets, they occupy about 60% of the global market. Scopolamine Hydrobromide is the main type, with a share about 45%. Patches is the main application, which holds a share about 60%.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Scopolamine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Alkaloids of Australia
Boehringer Ingelheim
Fine Chemicals Corporation
Phytex Australia
Alchem International
Guangzhou Hanfang
Alkaloids Corporation
Luyin
Segment by Type
Scopolamine Butylbromide
Scopolamine Hydrobromide
Others
Tablets
Injection
Patches
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Scopolamine market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Scopolamine, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Scopolamine industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Scopolamine in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Scopolamine introduction, etc. Scopolamine Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Scopolamine market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Scopolamine report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Scopolamine market is projected to reach US$ 15 million in 2034, increasing from US$ 11 million in 2022, with the CAGR of 4.2% during the period of 2024 to 2034. Demand from Tablets and Injection are the major drivers for the industry.
The major players in global Scopolamine market include Alkaloids of Australia, Boehringer Ingelheim, Fine Chemicals Corporation, etc. The top 3 players occupy about 55% shares of the global market. Australia and Europe are main markets, they occupy about 60% of the global market. Scopolamine Hydrobromide is the main type, with a share about 45%. Patches is the main application, which holds a share about 60%.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Scopolamine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Alkaloids of Australia
Boehringer Ingelheim
Fine Chemicals Corporation
Phytex Australia
Alchem International
Guangzhou Hanfang
Alkaloids Corporation
Luyin
Segment by Type
Scopolamine Butylbromide
Scopolamine Hydrobromide
Others
Segment by Application
Tablets
Injection
Patches
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Scopolamine market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Scopolamine, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Scopolamine industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Scopolamine in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Scopolamine introduction, etc. Scopolamine Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Scopolamine market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices